IN BRIEF: PureTech Health's Gelesis wins $15 million Plenity order

Writer,

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics - Investee Gelesis Holdings Inc receives another $15 million pre-order for its weight management aid product Plenity from its distribution partner, New-York based telehealth firm Ro. It brings the total orders from Ro to $55 million, out of which $45 million was ordered in the last 12 months, PureTech Health adds.

Current stock price: 166.60 pence, up 1.2% on Tuesday

12-month change: down 51%

Copyright 2022 Alliance News Limited. All Rights Reserved.